|
ARL17A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.352600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.792600E-01 |
| Normal-vs-Stage2 |
6.957200E-01 |
| Normal-vs-Stage3 |
1.843650E-01 |
| Normal-vs-Stage4 |
3.171000E-01 |
| Stage1-vs-Stage2 |
9.461800E-01 |
| Stage1-vs-Stage3 |
7.011600E-02 |
| Stage1-vs-Stage4 |
2.490200E-01 |
| Stage2-vs-Stage3 |
2.629400E-01 |
| Stage2-vs-Stage4 |
3.117000E-01 |
| Stage3-vs-Stage4 |
9.953000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.560400E-01 |
| Normal-vs-AfricanAmerican |
2.961000E-01 |
| Normal-vs-Asian |
3.514000E-01 |
| Caucasian-vs-AfricanAmerican |
1.568000E-02 |
| Caucasian-vs-Asian |
4.363000E-01 |
| AfricanAmerican-vs-Asian |
2.424000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.697400E-01 |
| Normal-vs-Female |
3.332100E-02 |
| Male-vs-Female |
2.935200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.038800E-01 |
| Normal-vs-Extreme_Weight |
8.854000E-01 |
| Normal-vs-Obese |
5.977600E-01 |
| Normal-vs-Extreme_Obese |
6.783000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.830000E-01 |
| Normal_Weight-vs-Obese |
1.649170E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.937200E-01 |
| Extreme_Weight-vs-Obese |
6.672200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.816200E-01 |
| Obese-vs-Extreme_Obese |
5.480000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.115000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.701800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.859600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.900400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.255600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.614850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.257370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.262800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.955160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.148000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.105000E-01 |
| Normal-VS-Type2 PRCC |
4.549700E-02 |
| Normal-VS-KIRP CIMP |
6.533000E-01 |
| Normal-VS-Unclassified PRCC |
5.157800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.88497999999981E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.285600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.689000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.274800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.998000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.814800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.831800E-01 |
| Normal-vs-N1 |
4.981600E-01 |
| Normal-vs-N2 |
6.904000E-01 |
| N0-vs-N1 |
9.749200E-01 |
| N0-vs-N2 |
9.579600E-01 |
| N1-vs-N2 |
9.771800E-01 |
|
|
